Analysts think ARTL stock price could increase by 272%
Feb 13, 2025, 12:25 PM
-30.64%
What does ARTL do
Artelo Biosciences, a clinical-stage biopharmaceutical company based in Solana Beach, California, focuses on developing therapeutics targeting lipid-signaling pathways and the endocannabinoid system. Its key programs include ART27.13 for anorexia and ART26.12 for cancer, pain, and anxiety.
6 analysts think ARTL stock price will increase by 272.26%. The current median analyst target is $5.10 compared to a current stock price of $1.37. The lowest analysts target is $4.04 and the highest analyst target is $6.30.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
